Zixun Dai

283 Tongzipo Road
Changsha, 410013, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Tenuigenin inhibits osteosarcoma growth via CIP2A/PP2A/NF-κB axis.

Tenuigenin inhibits osteosarcoma growth via CIP2A/PP2A/NF-κB axis.

Journal: Cancer chemotherapy and pharmacology
Published: June 27, 2024

Surface coating prolongs the degradation and maintains the mechanical strength of surgical suture in vivo.

Surface coating prolongs the degradation and maintains the mechanical strength of surgical suture in vivo.

Journal: Colloids and surfaces. B, Biointerfaces
Published: March 17, 2021

3D printing guide plate for accurate hemicortical bone tumor resection in metaphysis of distal femoral: a technical note.

3D printing guide plate for accurate hemicortical bone tumor resection in metaphysis of distal femoral: a technical note.

Journal: Journal of orthopaedic surgery and research
Published: January 31, 2021

Characterizations of Gene Alterations in Melanoma Patients from Chinese Population.

Characterizations of Gene Alterations in Melanoma Patients from Chinese Population.

Journal: BioMed research international
Published: May 31, 2019

Macrophage inhibits the osteogenesis of fibroblasts in ultrahigh molecular weight polyethylene (UHMWPE) wear particle-induced osteolysis.

Macrophage inhibits the osteogenesis of fibroblasts in ultrahigh molecular weight polyethylene (UHMWPE) wear particle-induced osteolysis.

Journal: Journal of orthopaedic surgery and research
Published: August 22, 2018

MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1.

MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1.

Journal: OncoTargets and therapy
Published: June 17, 2016

Alteration of the RANKL/RANK/OPG System in Periprosthetic Osteolysis with Septic Loosening.

Alteration of the RANKL/RANK/OPG System in Periprosthetic Osteolysis with Septic Loosening.

Journal: Inflammation
Published: August 22, 2015

Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells.

Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells.

Journal: Molecular medicine reports
Published: February 17, 2015

[Retracted] Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells.

[Retracted] Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells.

Journal: Molecular medicine reports
Published: February 17, 2015

Antitumor effect of resveratrol on chondrosarcoma cells via phosphoinositide 3-kinase/AKT and p38 mitogen-activated protein kinase pathways.

Antitumor effect of resveratrol on chondrosarcoma cells via phosphoinositide 3-kinase/AKT and p38 mitogen-activated protein kinase pathways.

Journal: Molecular medicine reports
Published: July 07, 2014

[Retracted] Antitumor effect of resveratrol on chondrosarcoma cells via phosphoinositide 3‑kinase/AKT and p38 mitogen‑activated protein kinase pathways.

[Retracted] Antitumor effect of resveratrol on chondrosarcoma cells via phosphoinositide 3‑kinase/AKT and p38 mitogen‑activated protein kinase pathways.

Journal: Molecular medicine reports
Published: July 07, 2014

[Retracted] microRNA‑145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.

[Retracted] microRNA‑145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.

Journal: Molecular medicine reports
Published: September 04, 2013
Showing 1-12 of 15

Last Updated: 09/26/2026